Thursday, 29 May 2014

Cambridge University-developed MS drug approved by watchdog


A new drug for treating multiple sclerosis, developed by Cambridge University research, has been approved for use by the National Institute for Health and Care Excellence (NICE).

The drug Lemtrada can reduce the effects of the disease and can, in certain cases, enable some recovery.  Read more here.